Eli Lilly Launches Attacks On Tirzepatide Generics
Eli Lilly and Co. fired off a round of lawsuits in Delaware federal court seeking to block generic versions of its tirzepatide weight loss and diabetes medications, targeting Sandoz, MSN Laboratories...To view the full article, register now.
Already a subscriber? Click here to view full article